Algert Global’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Algert Global’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,101	Closed	-$2.01M	–	1305
2023 Q2	$2.01M	Sell	51,101 -91,340	-64%	-$3.22M	0.09%	384
2023 Q1	$3.47M	Sell	142,441 -14,459	-9%	-$317K	0.16%	179
2022 Q4	$3.36M	Sell	156,900 -23,310	-13%	-$497K	0.19%	152
2022 Q3	$3.23M	Buy	180,210 +15,742	+10%	+$207K	0.2%	132
2022 Q2	$1.58M	Buy	164,468 +117,390	+249%	+$1.47M	0.12%	274
2022 Q1	$792K	Buy	47,078 +32,734	+228%	+$484K	0.05%	626
2021 Q4	$240K	Sell	14,344 -17,177	-54%	-$282K	0.03%	799
2021 Q3	$512K	Buy	31,521 +10,064	+47%	+$110K	0.07%	528
2021 Q2	$135K	Sell	21,457 -43,090	-67%	-$278K	0.05%	382
2021 Q1	$399K	Sell	64,547 -135,974	-68%	-$825K	0.13%	248
2020 Q4	$1.39M	Sell	200,521 -11,740	-6%	-$75.1K	0.4%	83
2020 Q3	$1.2M	Buy	212,261 +166,007	+359%	+$792K	0.38%	100
2020 Q2	$236K	Buy	46,254 +9,084	+24%	+$37.8K	0.08%	309
2020 Q1	$128K	Buy	+37,170	New	+$217K	0.05%	342

Algert Global's ISEE Position: Q3 2023 in Review

Algert Global sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 51,101 shares — an estimated $2.01M sold.

Algert Global first reported a position in ISEE in Q1 2020 and held it in 14 quarters. The position peaked at $3.47M in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Algert Global reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Algert Global sold 51,101 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.01M.
Algert Global first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
Algert Global's IVERIC bio, Inc. Common Stock position peaked at $3.47M in Q1 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Algert Global's 13F filing for Q3 2023, filed 13 Nov 2023.